PE
SNPS icon

PCM Encore’s Synopsys SNPS Stock Holding History

PCM Encore’s Portfolio SNPS Stock Details SNPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Sell
831
-11
-1% -$5.17K 0.07% 279
2026
Q1 		$334K Buy
842
+89
+12% +$40.2K 0.07% 285
2025
Q4 		$353K Buy
+753
New +$335K 0.08% 262

Other funds holding SNPS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Nvidia Corp Santa Clara, California $63.4B AUM 136.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

PCM Encore's SNPS Position: Q2 2026 in Review

PCM Encore reduced its Synopsys (SNPS) stake by 1.3% in Q2 2026, selling an estimated $5.17K and leaving 831 shares worth $371K. The position accounts for 0.07% of the portfolio, ranked #279.

PCM Encore first reported a position in SNPS in Q4 2025 and has held it in 3 quarters since. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • PCM Encore held 831 shares of Synopsys worth $371K as of Q2 2026.
  • PCM Encore sold 11 Synopsys shares in Q2 2026, an estimated $5.17K.
  • Synopsys made up 0.07% of PCM Encore's portfolio in Q2 2026, its #279 holding.
  • PCM Encore first reported a position in Synopsys in Q4 2025 and has held it in 3 quarters since.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.